NCT04242836

Brief Summary

Primary objective of our study is to develop and validate a computer-based digital near-vision optotype based on the Greek version of the print MNREAD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 8, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

3 months

First QC Date

January 8, 2020

Last Update Submit

January 24, 2020

Conditions

Keywords

digital near vision chartcritical print sizereading acuityreading speeddigital Greek MNREAD

Outcome Measures

Primary Outcomes (4)

  • Reading Acuity (RA)

    The smallest print that the patient can read without making significant errors, and can be calculated by the following formula: Acuity (in logMAR)= 1.4 - (sentences x 0.1) + (errors x 0.01).

    through study completion, an average of 8 months

  • Maximum Reading Speed (MRS)

    The patient's reading speed when reading is not limited by print size , and is calculated by averaging the speed of the sentences with print size larger than the CPS. \[(in words per minute (wpm)\]

    through study completion, an average of 8 months

  • Critical Print Size (CPS)

    The smallest print size at which patients can read with their MRS, and is identified as the print size of the sentence fulfilling this criterion: all of the following sentences are read at a speed that is 1.96 times the standard deviation below the average of the larger preceding sentences (that is the MRS). In other words, it is defined as the smallest print size that yields 90% of the MRS \[(in logMAR)\]

    through study completion, an average of 8 months

  • Accessibility Index (ACC)

    The mean reading speed measured across the 10 largest print sizes (1.3 to 0.4 logMAR) of the MNREAD Acuity Chart at 40 cm normalized by 200 wpm, which was the mean value for a group of 365 normally sighted young adults aged 18 to 39 years old.

    through study completion, an average of 8 months

Secondary Outcomes (2)

  • Intraclass Correlation Coefficients (ICCs) for study participants

    through study completion, an average of 8 months

  • Test-retest Intraclass Correlation Coefficients (ICCs)

    through study completion, an average of 8 months

Study Arms (2)

Control group

1. 70 patients with normal vision (NVG) with adequate literacy of written Greek language 2. 30 patients with low vision (LVG) with adequate literacy of written Greek language These patients are tested on the printed Greek MNREAD

Diagnostic Test: MNREAD testing

Study group

The same patients as those in the control group (NVG, LVG) are tested on the digital version of the Greek MNREAD (DeDART)

Diagnostic Test: MNREAD testing

Interventions

MNREAD testingDIAGNOSTIC_TEST

One randomly selected eye is included for each study participant. Participants respond to the near vision chart with defined environmental circumstances at 40cm viewing distance. All four parameters (RA, MRS, CPS and ACC) are evaluated.

Control groupStudy group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Normal- and low-sighted participants aged 18 to 75 years

You may qualify if:

  • adequate literacy of written Greek language

You may not qualify if:

  • dyslexia
  • attention-deficiency
  • former diagnosis of mental diseases
  • former diagnosis of psychiatric diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Alexandroupolis

Alexandroupoli, Evros, 68100, Greece

Location

Related Publications (1)

  • Labiris G, Panagiotopoulou EK, Chatzimichael E, Tzinava M, Mataftsi A, Delibasis K. Introduction of a digital near-vision reading test for normal and low vision adults: development and validation. Eye Vis (Lond). 2020 Oct 22;7:51. doi: 10.1186/s40662-020-00216-0. eCollection 2020.

MeSH Terms

Conditions

PresbyopiaVision, LowMyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye DiseasesVision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Georgios Labiris, MD, PhD

    University Hospital of Alexandroupolis, Alexandroupolis, Greece

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
15 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Ophthalmology

Study Record Dates

First Submitted

January 8, 2020

First Posted

January 27, 2020

Study Start

March 28, 2019

Primary Completion

June 28, 2019

Study Completion

November 28, 2019

Last Updated

January 27, 2020

Record last verified: 2020-01

Locations